Get started
Author

Azeem Saleem

Observed names: A Saleem, A. Saleem, Saleem, Azeem
Observed institutions: University of London, GlaxoSmithKline (United Kingdom), University of Hull, Washington University in St. Louis, Manchester Academic Health Science Centre, Beatson West of Scotland Cancer Centre, Mount Vernon Hospital, Castle Hill Hospital, Cancer Research UK, Hammersmith Hospital, Rigshospitalet, Clatterbridge Cancer Centre NHS Foundation Trust, University of Manchester, University of Oxford, Invicro (United Kingdom), Clatterbridge Hospital, Mount Vernon Cancer Centre, The Christie Hospital, The Christie NHS Foundation Trust, Addenbrooke's Hospital, Imperial College London, Hull York Medical School, Medical Research Council
ORCID: 0000-0002-5747-7577
Observed ORCID: 0000-0002-5747-7577
OpenAlex ID: A5034832196
A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients
2008 · Lula Rosso, Cathryn S. Brock, et al. · Cancer Research · 159
PDF
Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
2010 · Denis C. Talbot, Malcolm Ranson, et al. · Clinical Cancer Research · 100
Metabolic activation of temozolomide measured in vivo using positron emission tomography.
2003 · Azeem Saleem, Gavin D Brown, et al. · PubMed · 91
Pharmacokinetic Evaluation of N-[2-(Dimethylamino)Ethyl]Acridine-4-Carboxamide in Patients by Positron Emission Tomography
2001 · Azeem Saleem, Robert J. Harte, et al. · Journal of Clinical Oncology · 80
Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action
2000 · Azeem Saleem, Jeff Yap, et al. · The Lancet · 78
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098
2018 · Nicholas F Brown, Matthew Williams, et al. · Neuro-Oncology · 77
PDF
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
2015 · Azeem Saleem, Graham E Searle, et al. · EJNMMI Research · 76
PDF
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
2020 · Toby M. Maher, Juliet K. Simpson, et al. · Respiratory Research · 73
PDF
Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
2019 · Pauline T. Lukey, Christopher Coello, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 64
PDF
Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis Pannus
2018 · Nehal Narayan, David R. Owen, et al. · Journal of Nuclear Medicine · 63
PDF
Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge
2019 · David Erritzoe, Abhishekh H. Ashok, et al. · Neuropsychopharmacology · 53
PDF
Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors
2016 · Suraiya R. Dubash, Nicholas Keat, et al. · Journal of Nuclear Medicine · 45
PDF
Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.
2001 · E O Aboagye, A Saleem, et al. · PubMed · 43
Carbogen and Nicotinamide Increase Blood Flow and 5-Fluorouracil Delivery but not 5-Fluorouracil Retention in Colorectal Cancer Metastases in Patients
2006 · Nishi Gupta, Azeem Saleem, et al. · Clinical Cancer Research · 38
PDF
Radiolabelled Tracers and Anticancer Drugs for Assessment of Therapeutic Efficacy Using PET
2001 · Frank Brady, Sajinder Luthra, et al. · Current Pharmaceutical Design · 36
Early Tumor Drug Pharmacokinetics Is Influenced by Tumor Perfusion but not Plasma Drug Exposure
2008 · Azeem Saleem, Pat M. Price · Clinical Cancer Research · 34
Use of Positron Emission Tomography in Pharmacokinetic Studies to Investigate Therapeutic Advantage in a Phase I Study of 120-Hour Intravenous Infusion XR5000
2003 · D.J. Propper, J. de Bono, et al. · Journal of Clinical Oncology · 33
Clinical molecular imaging with positron emission tomography
2006 · Azeem Saleem, Natalie Charnley, et al. · European Journal of Cancer · 32
A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of18F-FB-A20FMDV2 for Imaging the Integrin αvβ6
2018 · Nicholas Keat, Julia Kenny, et al. · Journal of Nuclear Medicine Technology · 31
In vivo monitoring of drugs using radiotracer techniques
2000 · Azeem Saleem, Eric O Aboagye, et al. · Advanced Drug Delivery Reviews · 28
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies
2015 · Hatice Gungor, Azeem Saleem, et al. · Journal of Nuclear Medicine · 27
PDF
A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway
2015 · Azadeh Cheraghchi-Bashi, Christine A. Parker, et al. · Oncotarget · 24
PDF
Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue
2009 · Barbara Kötz, Catharine West, et al. · Molecular Cancer Therapeutics · 24
PDF
Integrin αvβ6 Positron Emission Tomography Imaging in Lung Cancer Patients Treated With Pulmonary Radiation Therapy
2020 · Azeem Saleem, Yusuf Helo, et al. · International Journal of Radiation Oncology*Biology*Physics · 21
Optimization of the Injected Activity in Dynamic 3D PET: A Generalized Approach Using Patient-Specific NECs as Demonstrated by a Series of15O-H2O Scans
2009 · Matthew D. Walker, Julian C. Matthews, et al. · Journal of Nuclear Medicine · 21
PDF
Works count: 95
Citation count: 1,612
H-index: 23
I10-index: 35
Year
Topic
Type